Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy

Laparoscopic Cholecystectomy Clinical Trial

Official title: Blockbuster LMA Versus Baska Mask in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial

Status Recruiting

Clinical Trial Summary

This study aimed to compare the performance and safety profiles of two supraglottic airway devices (SADs), the Blockbuster laryngeal mask airway (LMA) and the Baska Mask (BM), in patients underwent laparoscopic cholecystectomy (LC).

Clinical Trial Description

Laparoscopic surgery has become increasingly prevalent across numerous surgical disciplines due to the well-established benefits it offers over traditional open procedures. Laparoscopic cholecystectomy (LC), the surgical removal of the gallbladder, stands out as one of the most frequently performed laparoscopic operations worldwide. Supraglottic airway devices (SADs) play a crucial role in airway management algorithms, serving as viable alternatives in both anticipated and unanticipated difficult airway situations. The laryngeal mask airway (LMA) can be utilized to establish a routine airway during general anesthesia or, less frequently, as a conduit for tracheal intubation. Newer, improved LMA designs incorporate cuffs that provide higher sealing pressures than classic LMAs, while also allowing for the venting of gastric contents through a dedicated drain tube. The Baska Mask (BM), a second-generation SAD, features a non-inflatable cuff that is continuous with the airway channel, thereby inflating with positive pressure ventilation to improve cuff seal. ;

Related Conditions & MeSH terms

• Baska Mask
• Laparoscopic Cholecystectomy

• NCT number: NCT06395922
• Study type: Interventional
• Source: Tanta University
• Contact: Rabab M Mohamed, MD
• Phone: 00201069122935
• Email: rabmoh_30@outlook.com
• Status: Recruiting
• Phase: N/A
• Start date: February 6, 2024
• Completion date: June 1, 2024